Scrip: industry news and insights
ASCO - Servier’s Vorasidenib Puts The Brakes On Brain Cancer In INDIGO
04 Jun 2023
Servier’s targeted therapy, vorasidenib, can effectively delay the need for more drastic treatment in patients with low-grade glioma, but increases...